title: Activity-dependent modulation of neurotransmitter innervation to vasopressin neurons of the supraoptic nucleus.
abstract: Confocal microscopy was used to assess activity-dependent neuroplasticity in neurotransmitter innervation of vasopressin immunoreactive magnocellular neurons in the supraoptic nucleus (SON). Vesicular glutamate transporter 2, glutamic acid decarboxylase, and dopamine beta-hydroxylase (DBH) synaptic boutons were visualized in apposition to vasopressin neurons in the SON. A decrease in DBH synaptic boutons per cell was seen upon salt loading, indicating diminished noradrenergic/adrenergic innervation. Loss of DBH appositions to vasopressin neurons was associated with a general loss of DBH immunoreactivity in the SON. In contrast, the number of vesicular glutamate transporter 2 synaptic boutons per neuron increased with salt loading, consistent with increased glutamatergic drive of magnocellular SON neurons. Salt loading also caused an increase in the total number of glutamic acid decarboxylase synaptic boutons on vasopressinergic neurons, suggesting enhanced inhibitory innervation as well. These studies indicate that synaptic plasticity compensates for increased secretory demand and may indeed underlie increased secretion, perhaps via neurotransmitter-specific, activity-related changes in synaptic contacts on vasopressinergic magnocellular neurons in the SON.
authors.affiliation: Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio 45237-0506, USA.
authors.forename: Nancy K
authors.initials: NK
authors.lastname: Mueller
authors.forename: Shi
authors.initials: S
authors.lastname: Di
authors.forename: Charles M
authors.initials: CM
authors.lastname: Paden
authors.forename: James P
authors.initials: JP
authors.lastname: Herman
mesh_terms: D000818:Animals; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D005968:Glutamate Decarboxylase / Q000378:metabolism; D008297:Male; D026901:Membrane Transport Proteins / Q000378:metabolism; D009473:Neuronal Plasticity / Q000187:drug effects / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D018377:Neurotransmitter Agents / Q000502:physiology*; D017729:Presynaptic Terminals / Q000187:drug effects / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D012965:Sodium Chloride / Q000494:pharmacology; D013495:Supraoptic Nucleus / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D014667:Vasopressins / Q000502:physiology*; D050599:Vesicular Glutamate Transport Protein 2
chemical_list: D026901:Membrane Transport Proteins; D018377:Neurotransmitter Agents; C493475:Slc17a6 protein, rat; D050599:Vesicular Glutamate Transport Protein 2; D014667:Vasopressins; D012965:Sodium Chloride; D004299:Dopamine beta-Hydroxylase; D005968:Glutamate Decarboxylase